REPLICATE Dental Technologies successfully raised £430,000

This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded

Capital at risk

REPLICATE Dental Technologies

97%

Raised: £418,766

Investors: 289

Target: £430,000

Equity: 1.69%

Pre-money valuation: £24,965,139

REPLICATE is here to change single tooth replacement with a patented, patient-friendly product that does not require drilling or destroying healthy teeth. Focus is the £18 billion tooth replacement market in the USA. Clinically validated in Europe, U.S. FDA filings are complete, awaiting approval.

Unique, disruptive approach to single tooth replacement
Raised over £17M from founders, VCs and crowd investors
Clearance to sell in the EU
Founders are serial entrepreneurs, sold last dental company to 3M

Idea

Founders Pitch

REPLICATE Dental Technologies PLC (RDT), based in Dublin, Ireland has developed, tested and refined a minimally-invasive, patented medical device for replacing teeth, part of the growing trend toward personalized medicine.

The REPLICATE Immediate Tooth Replacement System disrupts the £38 billion dental market in the UK, USA, EU, South Korea and Japan, currently dominated by three-unit dental bridges (13.2 million units, 7% CAGR) and traditional dental implant screws (3.5 million units, 5% CAGR).

Over the past 5 years, the Company has worked on clinically validating its product at selected sites in Europe but has not widely launched the REPLICATE System as the primary market is the retail dental segment in the U.S., representing approximately 50% of dollars spent globally on dental procedures. RDT filed a 510(k) pre-market notification with the U.S. Food and Drug Administration (FDA) and is awaiting regulatory approval to sell in the U.S.

To date, the Company has raised £17 million from founders, management, business angels, and venture capital firms in the U.S. and Europe. £2.4 million was raised on the German crowd investing platform Companisto.

The Company currently has operations in Berlin, Germany and Dallas, Texas, and underwent a restructuring in 2018, forming RDT as a holding company to prepare for capital market entry on EuroNext.

To see the rest of the REPLICATE Dental Technologies pitch, join now.
It’s free, quick and easy.

Join

Already registered? Log in

To see the rest of the REPLICATE Dental Technologies pitch, join now.
It’s free, quick and easy.